NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening of its laboratory in Seattle NodThera Ltd(“NodThera” or the “Company”) NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening...

NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening of its laboratory in Seattle NodThera Ltd(“NodThera” or the “Company”) NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening...

NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer NodThera(“NodThera” or the “Company”) NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer             Dr Keeney joins NodThera with over 20 years of...

NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer NodThera(“NodThera” or the “Company”) NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer             Dr Keeney joins NodThera with over 20 years of...

NodThera secures £28 million ($40 million) Series A Financing NodThera(“NodThera” or the “Company”) NodThera secures £28 million ($40 million) Series A Financing NodThera discovers and develops next generation NLRP3 inflammasome inhibitors for the treatment...